Latest Medicine stories from Life.
In a significant shift at the Food and Drug Administration, Commissioner Marty Makary is stepping down following a challenging period in leadership, with Diamantas taking over.
As competition in the telehealth sector intensifies, Hims has reported a decline in sales. The company is navigating a challenging landscape, with significant developments in the biotech field.
Mark Webster, the pundit known for his insights on Premier League Darts, is scheduled to return to Sky Sports this Thursday following a positive update on his health after a cancer diagnosis.
STAT highlights the ongoing challenges America faces in tackling excessive alcohol consumption, revealing a historical pattern of neglect.
Pharmaceutical companies have ramped up their lobbying efforts, spending over $130 million in 2025, while Bristol-Myers Squibb has announced a new partnership with a Chinese firm.
The gene therapy community expresses concern over the lack of information from Capsida regarding the brain receptor involved in a recent fatal incident.
The name change from PCOS to PMOS, which stands for polyendocrine metabolic ovarian syndrome, was detailed in a recent publication, highlighting ongoing developments in the understanding of the condition.
A recent agreement among EU negotiators seeks to address the persistent drug shortages affecting the region by improving access to funding for essential medicine production.
The emotional toll of losing a pet extends beyond humans, affecting surviving animals as well. This piece reflects on the grief experienced by both parties.
After disembarking the last 28 passengers in Tenerife, the MV Hondius has set sail for the Netherlands with a reduced crew and medical team on board.
Recent reports indicate that significantly fewer seniors are utilizing expensive Alzheimer's medications than initially anticipated by Medicare.
Recent developments in biotech include Astellas' promising treatment for rare diseases, amid challenges in Alzheimer's drug rollout and insights from a China-based heart drug startup.
Following a confirmed hantavirus case in a French passenger from a cruise ship, Prime Minister Sebastien Lecornu is meeting with health officials to address the situation.
In a recent conversation, EMIN shared his profound admiration for Elvis Presley, describing it as an obsession akin to a drug. The meeting at Sea Breeze transcended a typical interview format.
Following a challenging period marked by both remarkable recoveries and tragic losses, Astellas is revisiting its gene therapy approach for XLMTM, offering renewed hope to affected families.
In a controversial move, the Trump administration has decided to discontinue Covid-19 vaccine safety studies, coinciding with a surge in anti-vaccine sentiments within the government.
In a recent discussion, Dr. Glaucomflecken highlights the necessity of maintaining local medical practices to better serve patients and communities, urging for national attention on the issue.
A new sensor, comparable in size to a grain of rice, promises to significantly improve the functionality of robots and medical devices by measuring forces and twisting motions using light.
Capricor Therapeutics has raised concerns about Nippon Shinyaku and its U.S. branch regarding the implementation of a treatment for Duchenne muscular dystrophy.
As discussions around mifepristone continue, former FDA leaders and pharmaceutical representatives raise critical questions about regulatory authority.